arrow_back Back to App

Opioid Drug Review: Assessing Public Health Risks and Non-Addictive Alternatives.

This legislation mandates the Department of Health and Human Services to create a plan for a comprehensive review of all approved opioid pain medications. The review must specifically consider the drugs' public health effects, such as addiction risk, as part of their benefit-risk assessment. This action aims to increase public safety regarding pain treatment and accelerate the development of safer, non-addictive alternatives.
Key points
Mandatory FDA review of all approved opioids to assess their public health impact, including addiction risks.
Focus on accelerating the development and approval of new, non-addictive medical products for treating pain and addiction.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_3557
Sponsor: Sen. Murphy, Christopher [D-CT]
Process start date: 2023-12-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A bill to require the Secretary of Health and Human Services to prepare a report that outlines a plan for completing a review of approved opioid analgesic drugs that considers the public health effects of such opioid drugs.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_3557.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-12-19.

What are the main provisions?

Key points include:

  • Mandatory FDA review of all approved opioids to assess their public health impact, including addiction risks.
  • Focus on accelerating the development and approval of new, non-addictive medical products for treating pain and addiction.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Murphy, Christopher [D-CT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health